JAK3 inhibitor

JAK3 inhibitor · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JAK3 inhibitor, covering 2008-05-30 to 2013-03-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients [Phase 2]